期刊
TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 14, 期 8, 页码 365-370出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2003.08.002
关键词
-
资金
- NICHD NIH HHS [P50 HD044405, U54 HD34449, P50 HD44405] Funding Source: Medline
Polycystic ovary syndrome (PCOS) is now recognized as an important metabolic and reproductive disorder. It is associated with substantial defects in insulin action and secretion that confer a markedly increased risk for type 2 diabetes mellitus. Insulin resistance modifies reproductive function both by the direct actions of insulin on steroidogenesis and by disruption of insulin signaling pathways in the central nervous system. These insights have led to a new therapy for PCOS with insulin-sensitizing agents. Hyperandrogenemia and insulin resistance cluster in PCOS families, consistent with a genetic susceptibility to these abnormalities. There is evidence for both linkage and association of the hyperandrogenemia phenotype with an allele of a marker locus on chromosome 19, in the region of the gene encoding the insulin receptor.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据